Loading...
FDFT1 Rabbit mAb

56407

FDFT1 Rabbit mAb

FDFT1 Rabbit mAb (catalogue number 56407) is a recombinant rabbit-derived primary antibody validated for WB IHC ICC/IF IP, reactive with Human Mouse Rat samples. It targets Squalene synthase (FDFT1): Catalyzes the condensation of 2 farnesyl pyrophosphate (FPP) moieties to form squalene. Supplied in 2 pack sizes, from 50ul at ₪1,015.65 to 100ul at ₪1,382.75; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRecombinant Rabbit
Host / source
Recombinant Rabbit
Reactivity
Human Mouse Rat
Applications
WB IHC ICC/IF IP
UniProt ID
P37268
Gene
FDFT1
Target organism
Homo sapiens
Catalogue number
56407
Brand
LABO Scientific
Storage
Store at -20°C. Avoid freeze/thaw cycles.

Target background

Target: Squalene synthase (FDFT1) · Homo sapiens

Catalyzes the condensation of 2 farnesyl pyrophosphate (FPP) moieties to form squalene. Proceeds in two distinct steps. In the first half-reaction, two molecules of FPP react to form the stable presqualene diphosphate intermediate (PSQPP), with concomitant release of a proton and a molecule of inorganic diphosphate. In the second half-reaction, PSQPP undergoes heterolysis, isomerization, and reduction with NADPH or NADH to form squalene. It is the first committed enzyme of the sterol biosynthesis pathway

Subcellular location: Endoplasmic reticulum membrane

Tissue specificity: Widely expressed

Sequence length: 417 aa · 48115 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C. Avoid freeze/thaw cycles.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.